Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current ideas in desmoid tumours.

N Julian H Sturt1, Susan K Clark

  • 1Polyposis Registry, Cancer Research UK Colorectal Cancer Unit, St Mark's Hospital, HA1 3UJ, Harrow, UK.

Familial Cancer
|September 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer.

Cancer discovery·2026
Same author

Outcomes following duodenectomy in patients with familial adenomatous polyposis.

Endoscopy international open·2024
Same author

PIGA Mutations and Glycosylphosphatidylinositol Anchor Dysregulation in Polyposis-Associated Duodenal Tumorigenesis.

Molecular cancer research : MCR·2024
Same author

The Diagnostic Yield of Genetic Testing in Patients With Multiple Colorectal Adenomas: A Specialist Center Cohort Study.

Clinical and translational gastroenterology·2023
Same author

Long-term outcomes of pouch surveillance and risk of neoplasia in familial adenomatous polyposis.

Endoscopy·2023
Same author

Altered Mucosal Immune-Microbiota Interactions in Familial Adenomatous Polyposis.

Clinical and translational gastroenterology·2022
Same journal

Peutz-Jeghers Syndrome and lung cancer: does the risk meet the threshold for lung cancer screening?

Familial cancer·2026
Same journal

Transitioning from the Prospective Lynch Syndrome Database (PLSD) to the International Lynch Syndrome Database (ILSD).

Familial cancer·2026
Same journal

Expanding access to hereditary cancer genetic testing: a quality improvement initiative of mainstreaming in a diverse urban gynecology clinic.

Familial cancer·2026
Same journal

When screentime fails: initiative to improve completion of hereditary cancer genetic testing after telemedicine counseling.

Familial cancer·2026
Same journal

The impact of international care networks on the clinical management of constitutional mismatch repair deficiency (CMMRD): a review of recent developments.

Familial cancer·2026
Same journal

Monoallelic NTHL1 p.(Gln90*) and cancer risk: evidence from a large Turkish cohort.

Familial cancer·2026
See all related articles

Desmoid tumors, rare fibroblastic neoplasms, frequently occur in familial adenomatous polyposis (FAP) patients. Management of these tumors remains a significant challenge in FAP care.

Area of Science:

  • Oncology
  • Genetics
  • Gastroenterology

Background:

  • Desmoid tumors are rare fibroblastic neoplasms with a high incidence in familial adenomatous polyposis (FAP) patients.
  • These tumors can be the leading cause of mortality post-colectomy in FAP individuals.
  • Risk factors include trauma, distal APC mutations, family history, and hormonal influences.

Purpose of the Study:

  • To review the current understanding of desmoid tumor development in FAP.
  • To discuss diagnostic imaging and treatment strategies for FAP-associated desmoids.
  • To highlight the ongoing challenges and future research directions in managing these neoplasms.

Main Methods:

  • Review of existing literature on desmoid tumors in FAP.
  • Analysis of tumor characteristics, genetic mutations (APC, beta-catenin), and telomere biology.

Related Experiment Videos

  • Evaluation of diagnostic modalities like CT and MRI.
  • Assessment of treatment outcomes for observation, medical therapy (sulindac, anti-estrogens), chemotherapy, and surgery.

    • Main Results:

    • FAP-associated desmoids often exhibit biallelic APC mutations, with loss of wild-type APC occurring late in tumorigenesis.
    • Beta-catenin is implicated in the pathogenesis of these tumors.
    • CT and MRI are crucial for anatomical and behavioral assessment.
    • Treatment varies from observation to sulindac, chemotherapy, or surgery, with varying risks.

    Conclusions:

    • Desmoid tumors represent a major management challenge in FAP.
    • Further research into etiology and multicenter clinical trials are essential for improved treatment strategies.
    • Understanding the genetic underpinnings and optimizing therapeutic approaches are critical for patient outcomes.